We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSS icon
3076
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$4K ﹤0.01%
41
-10
-20% -$1.01K
VT icon
3077
Vanguard Total World Stock ETF
VT
$81.3B
$4K ﹤0.01%
66
VUG icon
3078
Vanguard Morningstar Growth ETF
VUG
$230B
$4K ﹤0.01%
198
WSBC icon
3079
WesBanco
WSBC
$4B
$4K ﹤0.01%
108
+98
+980% +$4K
WSFS icon
3080
WSFS Financial
WSFS
$4.15B
$4K ﹤0.01%
+106
New +$4.46K
WTS icon
3081
Watts Water Technologies
WTS
$13.1B
$4K ﹤0.01%
69
-3,276
-98% -$235K
YHGJ icon
3082
Yunhong Green CTI Ltd
YHGJ
$7.83M
$4K ﹤0.01%
140
+22
+19% +$756
ZD icon
3083
Ziff Davis
ZD
$1.98B
$4K ﹤0.01%
63
-2,491
-98% -$157K
ZEPP
3084
Zepp Health
ZEPP
$69.7M
$4K ﹤0.01%
+94
New +$3.69K
ZTR
3085
Virtus Total Return Fund
ZTR
$339M
$4K ﹤0.01%
+400
New +$3.98K
CDMO
3086
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$4K ﹤0.01%
+887
New +$4.63K
ENLC
3087
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$4K ﹤0.01%
460
-490
-52% -$6.32K
EGRX
3088
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4K ﹤0.01%
+104
New +$5.36K
AFT
3089
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$4K ﹤0.01%
251
-2,749
-92% -$41.6K
CVLY
3090
DELISTED
Codorus Valley Bancorp Inc
CVLY
$4K ﹤0.01%
210
-155
-42% -$3.75K
NETI
3091
DELISTED
Eneti Inc.
NETI
$4K ﹤0.01%
87
+82
+1,640% +$4.68K
ID
3092
DELISTED
PARTS iD, Inc.
ID
$4K ﹤0.01%
375
+220
+142% +$2.14K
AENZ
3093
DELISTED
Aenza S.A.A.
AENZ
$4K ﹤0.01%
+424
New +$3.92K
AVTA
3094
DELISTED
Avantax, Inc. Common Stock
AVTA
$4K ﹤0.01%
153
-4,293
-97% -$131K
SNLN
3095
DELISTED
Highland/iBoxx Senior Loan ETF
SNLN
$4K ﹤0.01%
+207
New +$3.7K
GLOP
3096
DELISTED
GASLOG PARTNERS LP
GLOP
$4K ﹤0.01%
+181
New +$4.24K
APEN
3097
DELISTED
Apollo Endosurgery, Inc.
APEN
$4K ﹤0.01%
1,033
+486
+89% +$2.4K
AIMC
3098
DELISTED
Altra Industrial Motion Corp
AIMC
$4K ﹤0.01%
160
-310
-66% -$10.1K
SIOX
3099
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$4K ﹤0.01%
482
-1,038
-68% -$15K
LHCG
3100
DELISTED
LHC Group LLC
LHCG
$4K ﹤0.01%
+41
New +$3.92K

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.